As physicians enter a new world of therapies for molecularly defined lung cancer, it will be critical for hospitals, drug companies, and insurance companies to work out the interplay of molecular testing and coverage for expensive therapies that are effective but only in smaller, defined groups of patients.
Most patients with chronic musculoskeletal pain use acupuncture or chiropractic care. A substantial percentage of this utilization, however, is not captured by the electronic medical record.
A review of national Veterans Health Administration data has identified how the number of glucose-lowering agents used prior to insulin initiation impacts glycemic control.
Healthcare organizations and researchers should challenge themselves to provide increasingly timely data on cancer care disparities, until delays can be remedied as they happen.
A review of evidence about what works in 3 areas of value-based purchasing emphasized under healthcare reform: service delivery integration, payment, and value-based insurance design.
Complex interventions from hospital settings mapped to Omaha System terms commonly used in community care; demonstrating its potential as a tool for interoperability across settings.
We found no consistent associations between physician incentives for quality improvement and 12 measures of ambulatory quality of care.
This study found that the dramatic shift from face-to-face posthospital transitional care to telehealth did not affect 30-day readmission or mortality during the COVID-19 pandemic.
Pilot program implemented at Hackensack ACO that provides hospitals and ACOs an early warning system to manage their highest risk patients.
Medicare prospective payment for dialysis modestly increased availability and use of home-based dialysis treatment but did not affect historic racial disparities in home dialysis.
Palliative care is an underutilized and powerful resource in the drive towards value. In the current article, we review published evidence and highlight how Medicare Advantage plans, accountable care organizations, and oncology practices can benefit from concurrent palliative care under value-based payments.
San Francisco is attempting to expand health insurance coverage and access to care while also supporting its healthcare safety net.
Nurse practitioner comanagment improved quality of care for 5 chronic conditions in an academic geriatrics practice.
The mean 24-week cost per participant was $5416 for extended-release injectable naltrexone (57% detoxification, 37% medication, 6% provider/patient) and $4148 for buprenorphine-naloxone (64% detoxification, 12% medication, 24% provider/patient).
In 2012, electronic health record use and participation in accountable care organization or patient-centered medical home initiatives were associated with performing care processes expected to improve healthcare outcomes.
Care episodes treated in retail clinics appeared to be less complex than those treated in office settings.
Costs of potentially avoidable complications have significantly more variation than costs of typical care in selected chronic and procedural episodes.
An economic model based on the ECHELON-2 trial demonstrated cost-effectiveness of brentuximab vedotin with chemotherapy in frontline treatment of CD30-expressing peripheral T-cell lymphoma (PTCL).
Affordable Care Act exchange enrollees in California and Colorado reported significant improvements in access to care and fewer barriers to receiving care due to costs.